The invention provides a novel chemical series of formula I, as well as methods of use thereof for binding to the benzodiazepine site of the GABAA receptor and negatively modulating the α5 subtype of GABAA, and use of the compound of
-
Page/Page column 21
(2012/04/23)
More Articles about upstream products of 100478-04-4